Adverse event reporting in oncology clinical trials - lost in translation?

Shanthi Sivendran; Matthew D. Galsky

doi:10.1080/14740338.2016.1175429

Adverse event reporting in oncology clinical trials - lost in translation?

Research output: Contribution to journal › Editorial

12 Scopus citations

Original language	English
Pages (from-to)	893-896
Number of pages	4
Journal	Expert Opinion on Drug Safety
Volume	15
Issue number	7
DOIs	https://doi.org/10.1080/14740338.2016.1175429
State	Published - 2 Jul 2016

Keywords

Adverse event
CONSORT
attribution
harms
patient reported outcomes

Access to Document

10.1080/14740338.2016.1175429

Cite this

@article{9cd1473529f94b8e8c3ae6f801834b99,

title = "Adverse event reporting in oncology clinical trials - lost in translation?",

keywords = "Adverse event, CONSORT, attribution, harms, patient reported outcomes",

author = "Shanthi Sivendran and Galsky, {Matthew D.}",

year = "2016",

month = jul,

day = "2",

doi = "10.1080/14740338.2016.1175429",

language = "English",

volume = "15",

pages = "893--896",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",